Allergic rhinitis-asthma syndrome
Conditions
Interventions
Test group:Thermal moxibustion + inhaled budesonide suspension group
Control group:inhaled budesonide suspension group
Sponsors
Affiliated Hospital of Jiangxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.the Western diagnostic criteria for allergic rhinitis-asthma syndrome were met [5,13], with asthma in non-clinical remission and a mild to moderate severity rating. 2. The TCM diagnosis of "congested nose" and "croup" is met . 3. Age 20-60 years. 4. Voluntary participation in the study and signed informed consent. 5. Patients were in good mental condition and could correctly express the sensation of heat-sensitive moxibustion.
Exclusion criteria
Exclusion criteria: 1. Asthma caused by severe asthma, mycobacterium tuberculosis, tumours and other severe factors. 2. Patients with other non-allergic rhinitis such as combined sinusitis, sinus and nasal cysts, nasal polyps, nasal vestibulitis; patients with combined respiratory diseases such as upper respiratory tract infection, chronic obstructive pulmonary disease, tuberculosis, etc. 3. Patients with skin lesions or ulcers at the moxibustion site that are not suitable for moxibustion. 4. Patients with serious life-threatening primary diseases such as cardiovascular, cerebrovascular, liver, kidney and haematopoietic system, as well as psychiatric patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Criteria for determining efficacy;Efficacy observation score;Lung Function Test; | — |
Countries
Chian
Contacts
Public ContactJun Li
Affiliated Hospital of Jiangxi University of Chinese Medicine
Outcome results
None listed